Intra-Cellular Therapies Inc (ITCI)
73.33
+1.20
(+1.66%)
USD |
NASDAQ |
Apr 26, 16:00
73.33
0.00 (0.00%)
After-Hours: 16:55
Intra-Cellular Therapies Total Assets (Quarterly): 728.30M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 728.30M |
| September 30, 2023 | 717.66M |
| June 30, 2023 | 713.60M |
| March 31, 2023 | 722.16M |
| December 31, 2022 | 754.78M |
| September 30, 2022 | 782.00M |
| June 30, 2022 | 811.91M |
| March 31, 2022 | 868.58M |
| December 31, 2021 | 489.92M |
| September 30, 2021 | 556.98M |
| June 30, 2021 | 625.70M |
| March 31, 2021 | 674.49M |
| December 31, 2020 | 717.31M |
| September 30, 2020 | 771.29M |
| June 30, 2020 | 440.93M |
| March 31, 2020 | 481.24M |
| December 31, 2019 | 251.19M |
| September 30, 2019 | 280.52M |
| June 30, 2019 | 309.86M |
| March 31, 2019 | 342.97M |
| December 31, 2018 | 357.21M |
| September 30, 2018 | 385.59M |
| Date | Value |
|---|---|
| June 30, 2018 | 412.07M |
| March 31, 2018 | 445.64M |
| December 31, 2017 | 471.49M |
| September 30, 2017 | 334.19M |
| June 30, 2017 | 349.54M |
| March 31, 2017 | 372.29M |
| December 31, 2016 | 388.90M |
| September 30, 2016 | 542.57M |
| June 30, 2016 | 447.60M |
| March 31, 2016 | 463.66M |
| December 31, 2015 | 484.10M |
| September 30, 2015 | 513.12M |
| June 30, 2015 | 213.40M |
| March 31, 2015 | 237.13M |
| December 31, 2014 | 131.11M |
| September 30, 2014 | 137.61M |
| June 30, 2014 | 141.34M |
| March 31, 2014 | 146.64M |
| December 31, 2013 | 38.45M |
| September 30, 2013 | 47.34M |
| June 30, 2013 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
251.19M
Minimum
Dec 2019
868.58M
Maximum
Mar 2022
615.71M
Average
713.60M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Insmed Inc | 1.330B |
| Fate Therapeutics Inc | 506.22M |
| ADMA Biologics Inc | 329.18M |
| Jaguar Health Inc | 50.76M |
| Rhythm Pharmaceuticals Inc | 332.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 136.87M |
| Shareholders Equity (Quarterly) | 591.42M |
| Current Ratio | 5.405 |